releasing hormone
Gonadotropin-Releasing Hormone (GnRH) Agonist Trigger in a GnRH Antagonist Protocol and Severe Ovarian Hyperstimulation Syndrome
... Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic, severe, and potentially life- threatening complication of ovarian stimulation, and it occurs in approximately 1%–14% of assisted reproductive technique (ART) ...
5
Original Article Efficacy and toxicity between luteinising hormone releasing hormone analogue therapy and maximal androgen blockade therapy in patients with advanced prostate cancer in China
... luteinising hormone releasing hormone analogue (LHRH-a) therapy and maximal androgen blockade (MAB) therapy in patients with advanced prostate cancer in ...
5
Combined Use of Growth Hormone and Gonadotropin-releasing Hormone Analogues: The National Cooperative Growth Study Experience
... ABSTRACT. Gonadotropin-releasing hormone ana- logues (GnRHa) are used to treat central precocious pu- berty. They also are used to delay puberty in short chil- dren with a prognosis for impaired adult ...
6
Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes
... luteinizing hormone-releasing hormone (LHRH) receptor overexpressing cells, was developed to promote the efficiency of intracellular delivery of mitoxantrone through receptor-mediated ...
9
Direct effects of catecholamines, thyrotropin releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture
... thyrotropin-releasing hormone (TRH)1 and somatostatin on pituitary hormone release in patients with acromegaly and in normal subjects, the effects of these substances on growth hormone (GH) ...
14
Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels
... Materials and methods: Previously, we reported the effect of a luteinizing hormone-releasing hormone (LH-RH) agonist on testicular and adrenal androgen production in patients with prostate cancer. A ...
8
Measurement of growth hormone releasing hormone and somatostatin in hypothalamic portal plasma of unanesthetized sheep Spontaneous secretion and response to insulin induced hypoglycemia
... growth hormone (GH)-releasing hormone (GRH) and somatostatin (SRIH) in the regulation of the growth hormone (GH) secretory pattern, we collected portal blood from five unanesthetized ...
9
Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche
... luteinizing hormone releasing hormone (LHRHa) affords an opportunity to examine the onset and progression of adrenarche in the absence of pubertal levels of gonadal steroids in a controlled fashion ...
7
Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin releasing hormone in corticotropin releasing hormone deficient mice
... Corticotropin-releasing hormone (CRH; 10), a 41–amino acid peptide synthesized in the paraventricular nucleus of the hypothalamus, has been implicated by immu- noneutralization studies in the generation of ...
8
Regulation of pituitary gonadotropin releasing hormone receptors by pulsatile gonadotropin releasing hormone injections in male rats Modulation by testosterone
... gonadotropin-releasing hormone (GnRH) stimulus is critically important in the regulation of pituitary gonadotropin secretion and continuous infusions down-regulate secretion while intermittent pulses ...
10
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
... Prostate cancer (PCa) is one of the most common can- cers worldwide, with a survival rate that is relatively high in comparison with that of other cancers, partially due to the effectiveness of androgen deprivation ...
7
Immunocytochemical evidence for growth hormone-releasing hormone in the tanycytes of the median eminence of the rat
... To obtain the primary antibodies against rat GHRH, rat GHRH (amino acids 1–43) was conjugat- ed to bovine thyroglobulin using the coupling re- agent carbodiimide. This complex, containing 1.2 mg of rat GHRH, was ...
8
Social regulation of gonadotropin releasing hormone
... gonadotropin-releasing hormone (GnRH) delivered by hypothalamic neurons to the pituitary gland, regulates reproduction through release of pituitary gonadotropins that regulate gonadal function (Cattanach et ...
15
Thyroid Hormone Inhibition of the Prolactin Response to Thyrotropin Releasing Hormone
... The influence of serum triiodothyronine (T 3 ) and thyroxine (T 4 ) concentrations on the release of prolactin in man was studied by determining the prolactin response to synthetic thyrotropin-releasing ...
7
Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients: a retrospective study
... gonadotropin-releasing hormone (GnRH) agonist combined with hormone replacement treatment (GnRHa-HRT), as another FET protocol [5 – 7], has been shown to be successful in patients with endometriosis ...
9
Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin releasing hormone
... Synthetic thyrotropin-releasing hormone (TRH) was administered to normal children and hypopituitary patients in a dose of 7 µg/kg i.v. over 30-60 sec. Serum thyrotropin (TSH) and prolactin (HPr) ...
9
Effect of very high dose D leucine6 gonadotropin releasing hormone proethylamide on the hypothalamic pituitary testicular axis in patients with prostatic cancer
... antireproductive effects when administered chronically. These compounds are minimally toxic and may exhibit no plateau of the dose-response curve even at very high doses. These considerations served as the basis for our ...
13
Serum Thyrotropin Responses to Synthetic Thyrotropin Releasing Hormone in Normal Children and Hypopituitary Patients A NEW TEST TO DISTINGUISH PRIMARY RELEASING HORMONE DEFICIENCY FROM PRIMARY PITUITARY HORMONE DEFICIENCY
... thyrotropin-releasing hormone (TRH) was administered intravenously in a dose of 7 µg/kg to 20 normal children ages 4-13 ...thyroid-stimulating hormone (TSH) was measured by radioimmunoassay and rose ...
8
Treatment with Luteinizing Hormone-Releasing Hormone Antagonists: is Serum Testosterone Reduction the Only Mechanism?
... Besides suppression of luteinizing hormone (LH), LHRH agonists and LHRH antagonists also suppress follicle stimulating hormone (FSH) levels [5]. The FSH receptor is expressed in normal human prostatic ...
5
Oxytocin and Stress Response
... adrenocorticotropic hormone (ACTH) from the anterior pituitary ...corticotropin releasing hormone (CRH) controls ACTH release via oxytocin and its receptors ...
12